Concomitant up-regulation of proopiomelanocortin and dopamine D2-receptor gene expression in the pituitary intermediate lobe of the spontaneously hypertensive rat

Journal of Neuroendocrinology

Volumn 9, Issue 4, 1997, Pages 255-262

  Autelitano, Dominic J ^a   Van Den Buuse, Maarten ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Dopamine D2 receptor; POMC; Spontaneously hypertensive rat

Indexed keywords

BROMOCRIPTINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; MESSENGER RNA; PROOPIOMELANOCORTIN; QUINPIROLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE EXPRESSION REGULATION; HYPOPHYSIS INTERMEDIATE LOBE; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030963349     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1997.00576.x     Document Type: Article

References (45)

1. Van den Buuse M, De Jong W. Pharmacology of central dopaminergic modulation in hypertension. In: Saito H, Minami M and Parvez SH eds. Progr in Hypertension, Antihypertensive Drugs Today. Zeist: VSP Press, 1991; vol 2: 157-188.
2. Fuller RW, Hemrick-Luecke SK, Wong DT, Pearson D, Threllkeld PG, Hynes MD. Altered behavioural response to a D-2 agonist, LY141865, in SHR exhibiting biochemical and endocrine responses similar to those in normotensive rats. J Pharmacol Exp Ther 1983; 227: 354-359.
3. Van den Buuse M. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats. J Pharmacology Exp Ther 1992; 262: 303-311.
4. Van den Buuse M, Jones CR, Wagner J. Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats. Brain Res Bull 1992; 28: 289-297.
5. Tan BKH, Hutchinson JS. Plasma and pituitary prolactin and blood pressure in bromocriptine-treated spontaneously hypertensive and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol 1987; 14: 797-803.
6. Lundblad JR, Roberts JL. Regulation of proopiomelanocortin gene expression in pituitary. Endocrine Reviews 1988; 9: 135-158.
7. Autelitano DJ, Lundblad JR, Blum M, Roberts JL. Hormonal regulation of POMC gene expression. Ann Rev Physiology 1989; 51: 715-726.
8. Goudreau JL, Lindley SE, Lookingland KJ, Moore KE. Functional and neurochemical evidence that periventricular dopamine neurons innervate the intermediate lobe of the rat pituitary. Neuroendocrinology 1992; 56: 100-105.
9. Goudreau JL, Falls WM, Lookingland KJ, Moore KE. Periventricular-hypophysial dopaminergic neurons innervate the intermediate but not the neural lobe of the rat pituitary gland. Neuroendocrinology 1995; 62: 147-154.
10. Penny RJ, Thody AJ. An improved radioimmunoassay for α-melanocyte-stimulating hormone (α-MSH) in the rat: serum and pituitary α-MSH levels after drugs which modify catecholaminergic neurotransmission. Neuroendocrinology 1978; 25: 193-203.
11. Tilders FJH, Smelik PG. Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats. Neuroendocrinology 1978; 25: 275-290.
12. Munemura M, Cote TE, Tsuruta K, Eskay RL, Kebabian JW. The dopamine receptor in the intermediate lobe of the rat pituitary gland: pharmacological characterization. Endocrinology 1980; 107: 1676-1683.
13. Hollt V, Haarman I, Seizinger BR, Herz A. Chronic haloperidol treatment increases the level of in vitro translatable messenger ribonucleic acid coding for the β-endorphin/adrenocorticotropin precursor proopiomelanocortin in the pars intermedia of the rat pituitary. Endocrinology 1982; 110: 1885-1891.
14. Chen C-L, C, Dionne FT, Roberts JL. Regulation of the proopiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds. Proc Natl Acad Sci USA 1983; 80: 2211-2215.
15. Hutchinson JS, Di Nicolantonio R, Lim A, Clements J, Funder JW. Effects of bromocriptine on blood pressure and plasma β-endorphin in spontaneously hypertensive rats. Clin Sci 1981; 61: 343s-345s.
16. Gaida W, Lang RE, Kraft K, Unger T, Ganten D. Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence? Clin Sci 1985; 68: 35-43.
17. Li S-J, Wong SC, Hong J-S, Ingenito AJ. Age-related changes in opioid peptide concentrations in brain and pituitary of spontaneously hypertensive rats. Pharmacology 1992; 44: 245-256.
18. Burt DR, Creese I, Snyder SH. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 1977; 196: 326-328.
19. Autelitano DJ, Snyder L, Sealfon SC, Roberts JL. Dopamine D2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior pituitary and neurointermediate pituitary. Mol Cell Endocrinol 1989; 67: 101-105.
20. Le Moine C, Normand E, Guitteny AF, Fouque B, Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc Natl Acad Sci USA 1990; 87: 230-234.
21. Neve KA, Neve RL, Fidel S, Janowsky A, Higgins GA. Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation. Proc Natl Acad Sci USA 1991; 88: 2802-2806.
22. Chronwall BM, Dickerson DS, Huerter BS, Sibley DR, Millington WR. Regulation of heterogeneity in D2 dopamine receptor gene expression among individual melanotropes in the rat pituitary intermediate lobe. Mol Cell Neurosci 1994; 5: 35-45.
23. Autelitano DJ, Van den Buuse M. Altered expression of dopamine D2 receptor mRNA splice variants in brain and pituitary of spontaneously hypertensive rats. Neurosci Lett 1995; 195: 1-4.
24. Seger MA, Kiss JZ, Van Tol HHM, Burbach JPH. Biosynthesis of pro-opiomelanocortin is increased in the rat intermediate pituitary following denervation. Neurosci Lett 1987; 83: 149-155.
25. Morris M, Sundberg DK. Neurohypophyseal dopamine biosynthesis in the spontaneously hypertensive rat. Clin Exp Hypertension 1981; 3: 1165-1181.
26. Agui T, Amlaiky N, Caron MG, Kebabian JW. Agonist-induced desensitization of the D-2 dopamine receptor in the intermediate lobe of the rat pituitary. J Biochem 1988; 103: 436-441.
27. Vallar L, Muca C, Magni M, Albert P, Bunzow J, Meldolesi J, Civelli O. Differential coupling of dopaminergic D2 receptors expressed in different cell types. J Biol Chem 1990; 265: 10320-10326.
28. Montmayeur J-P, Borrelli E. Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci USA 1991; 88: 3135-3139.
29. Hayes G, Biden TJ, Selbie LA, Shine J. Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line. Mol Endocrinol 1992; 6: 920-926.
30. Rogue P, Malviya AN. Regulation of signalling pathways to the nucleus by dopaminergic receptors. Cell Signalling 1994; 6: 725-733.
31. Montmayeur J-P, Guiramand J, Borrelli E. Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol 1993; 7: 161-170.
32. Loeffler J-P, Demeneix BA, Pittius CW, Kley N, Haegele KD, Hollt V. GABA differentially regulates the gene expression of proopiomelanocortin in rat intermediate and anterior pituitary. Peptides 1986; 7: 253-258.
33. Meunier H, Lefevre G, Dumont D, Labrie F. CRF stimulates α-MSH secretion and cyclic AMP accumulation in rat pars intermedia cells. Life Sci 1982; 31: 2129-2135.
34. Munemura M, Eskay RL, Kebabian JW. Release of α-melanocyte-stimulating hormone from dispersed cells of the intermediate lobe of the rat pituitary gland: involvement of catecholamines and adenosine 3′,5′-monophosphate. Endocrinology 1980; 106: 1795-1803.
35. 3H] thymidine uptake measurement. Endocrinology 1987; 120: 1201-1211.
36. Chronwall BM, Hook GR, Millington WR. Dopaminergic regulation of the biosynthetic activity of individual melanotropes in the rat pituitary intermediate lobe: a morphometric analysis by light and electron microscopy and in situ hybridization. Endocrinology 1988; 123: 1992-2002.
37. 2+ channel activity via c-fos. Endocrinology 1995; 136: 614-621.
38. Tandon A, Collier B, Zhang ZW, Feltz P. Acetylcholine synthesis in a primary culture of porcine intermediate lobe cells. J Neuroendocr 1991; 3: 273-277.
39. Ocrant I, Valentino KL, Hoffman AR, Hintz RL, Wilson DM, Rosenfeld RG. Structural characterization and immunohistochemical localization of receptors for insulin-like growth factor 11 in the rat pituitary gland. Neuroendocrinology 1989; 49: 248-254.
40. Stepien H, Zerek-Melen G, Mucha S, Winczyk K, Fryczak J. Interleukin-1 beta stimulates cell proliferation in the intermediate lobe of the rat pituitary gland. J Endocrinol 1994; 140: 337-341.
41. Vinson GP, Whitehouse BJ, Dell A, Etienne T, Morris HR. Characterisation of an adrenal zona glomerulosa-stimulating component of posterior pituitary extracts as α-MSH. Nature 1980; 284: 464-467.
42. Gruber KA, Klein MC, Hutchins PM, Buekalew Jr VM, Lymangrover JR. Natriuretic and hypertensive activities reside in a fragment of ACTH. Hypertension 1984; 6: 468-474.
43. Samson WK, Skala KD, Alexander BD, Huang F-L, S, Gomez-Sanchez C. A prolactin release inhibiting activity from neurointermediate lobe extracts is an endothelin-like peptide. Reg Peptides 1992; 39: 103-112.
44. Autelitano DJ, Blum M, Roberts JL. Changes in rat pituitary nuclear and cytoplasmic pro-opiomelanocortin RNAs associated with adrenalectomy and glucocorticoid replacement. Mol Cell Endocrinol 1989; 66: 171-180.
45. Lim AT, Khalid BAK, Clements J, Funder JW. Glucocorticoid and mineralocorticoid effects on adrenocorticotropin and β-endorphin in the adrenalectomized rat. J Clin Invest 1982; 69: 1191-1198.